Abacus Global Management’s Defamation Suit Against Coventry and its Chairman Alan Buerger Advances in U.S. District Court

Rhea-AI Summary

News Market Reaction – ABX

+7.25%

+7.25% Session close to close

In the Jun 26 session, ABX gained 7.25%, reflecting a notable positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +7.3% in the session following this news. A strong positive reaction aligns with the...

Analysis

The stock moved +7.3% in the session following this news. A strong positive reaction aligns with the court’s validation of Abacus’s defamation and anticompetitive-conduct claims, reinforcing its competitive narrative. Elevated short positioning could amplify upside but also create risks if legal outcomes or sentiment later turn.

Historical Context

5 past events · Latest: Jun 11 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jun 11	Conference participation	Neutral	+3.2%	Announcement of participation in Northland Growth Conference with investor meetings.
Jun 10	Product/AI launch	Positive	+1.9%	Launch of LifeARC AI lifespan platform and highlighting strategic investment exposure.
Jun 05	Recognition/award	Positive	-1.2%	Inclusion in TIME's World's Growth Leaders list for strong growth and stability.
May 27	Strategic alliance	Positive	-2.5%	Strategic alliance and minority equity investment with wealth manager Manning & Napier.
May 13	Conference participation	Neutral	-1.0%	Participation in B. Riley investor conference with executive investor meetings.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Recent company news, often promotional or strategic, has produced mixed reactions with a slight tilt toward negative follow-through after announcements.

Key Terms

defamation, anticompetitive conduct, depositions, punitive damages

4 terms

defamation regulatory

"The Court’s decision found that Abacus alleged plausible claims of defamation and anticompetitive conduct"

An untrue statement presented as fact that harms a person’s or company’s reputation, like a rumor printed or broadcast as news; written defamation is often called libel and spoken defamation is called slander. Investors care because defamation claims can trigger costly lawsuits, regulatory attention, lost customers or partners, and sudden swings in market value — similar to how a damaging rumor can quickly erode trust in someone you would otherwise do business with.

anticompetitive conduct regulatory

"The Court’s decision found that Abacus alleged plausible claims of defamation and anticompetitive conduct"

Anticompetitive conduct is behavior by a company that unfairly limits competition—examples include price‑fixing, exclusive deals that lock out rivals, tying products together, or using dominant market power to squeeze competitors. Investors care because such actions can trigger regulatory investigations, heavy fines, lawsuits or forced changes to business practices; like a player bending the rules to win, it can lift short‑term profits but create legal risk and long‑term damage to shareholder value.

depositions regulatory

"The case will now proceed with depositions of top Coventry executives, including Buerger"

Depositions are sworn, recorded question-and-answer sessions held outside of court where witnesses or company representatives describe events and facts under oath. Think of them as a taped rehearsal of testimony that can reveal inconsistencies, admissions, or new facts; that information can change how likely a company is to win a case, the size of potential damages, or the chance of a costly settlement, all of which matter to investors.

punitive damages regulatory

"allows the company to press its suit for economic and punitive damages, and to compensate itself"

Punitive damages are extra money a court orders a company or individual to pay beyond the actual loss, intended to punish particularly wrongful conduct and discourage others from doing the same. For investors, punitive damages can signal reputational and financial risk—like a surprise fine that reduces profits and cash on hand—so they matter because they can affect future dividends, credit ratings, and share price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Federal Court Finds Abacus Plausibly Alleged a “scheme to destroy Abacus” and Denies Coventry’s Motion to Dismiss – Depositions, including Chairman Buerger and Coventry Executive Team to Move Ahead

Abacus Alleged a Years-Long Campaign to Systematically Disseminate False and Misleading Information About the Publicly-Traded Company

ORLANDO, Fla., June 26, 2026 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. (“Abacus” or the “Company”) (NYSE: ABX), a leader in the alternative asset management space, announced a favorable ruling from the U.S. District Court, Middle District of Florida Orlando Division today in Abacus’s lawsuit against Coventry First LLC, parent company of life settlements provider Coventry Direct (“Coventry”), and its Chairman Alan Buerger. The Court’s decision found that Abacus alleged plausible claims of defamation and anticompetitive conduct and denied Coventry’s Motion to Dismiss. The case will now proceed with depositions of top Coventry executives, including Buerger, whom Abacus believes possess evidence of, in the Court’s words, Coventry’s “scheme to destroy Abacus.” Today’s ruling can be found here.

In July 2025, Abacus sued Coventry and its Chairman Buerger, detailing a concentrated effort by Coventry and Buerger to manipulate market sentiment about its biggest competitor, Abacus, through a slew of false and misleading statements to regulators, auditors, market analysts, customers, investors and the public. This onslaught was designed to cause confusion, concern, and financial injury to Abacus, its clients, and its shareholders. Today’s decision, finding that Abacus has “successfully pled defamation claims,” allows the company to press its suit for economic and punitive damages, and to compensate itself for those reputational harms.

“The court wiped away any impediment to this case going forward and confirmed we’ve presented real, credible, and plausible information about a scheme to destroy Abacus through malfeasance,” said Abacus Global Management CEO Jay Jackson. “Coventry has been losing market share because we offer policyholders better terms and more transparent pricing, so instead of competing, they tried to manipulate markets. Yet while we live in a world filled with people who profit from peddling materially false information, the court today stood up and said this case has merit and is moving ahead.”

Now Abacus will have the chance to uncover the details of Coventry’s attempts to obscure the bottom line of Abacus’s success, as described in the Amended Complaint: “Coventry's false narrative attempts to project its own financial vulnerabilities onto Abacus, but the facts demonstrate otherwise. The market analysts who came to Abacus’ defense . . . recognize the truth: Abacus’ transparent approach is a ray of sunshine in an otherwise beleaguered industry, and that explains its rapid rise.”

Abacus is represented in the lawsuit by Quinn Emanuel Urquhart & Sullivan LLP. Abacus is seeking hundreds of millions in damages, some of which are still accruing, from the harms to its reputation, its customer base, and its relationships with current and potential investors.

The original lawsuit can be read here.

Today’s ruling, which allows the lawsuit to advance, can be found here.

About Abacus

Abacus Global Management (NYSE: ABX) is a leading financial services company specializing in alternative asset management, data-driven wealth solutions, technology innovations, and institutional services. With a focus on longevity-based assets and personalized financial planning, Abacus leverages proprietary data analytics and decades of industry expertise to deliver innovative solutions that optimize financial outcomes for individuals and institutions worldwide.

For more information, please visit www.abacusgm.com.

Contacts:

Investor Relations
David Jackson – Managing Director of Investor Relations
david@abacusgm.com | (321) 299-0716

Public Relations
press@abacusgm.com